Abciximab treatment modalities for thromboembolic events related to aneurysm coiling
M Aggour, L Pierot, K Kadziolka, P Gomis… - Operative …, 2010 - journals.lww.com
BACKGROUND: Thromboembolic complications are the most common cause of
periprocedural morbidity associated with the endovascular treatment of intracranial
aneurysms with detachable coils. OBJECTIVE: To estimate the safety and efficacy of using
combined intra-arterial and intravenous abciximab to treat thrombi complicating
endovascular cerebral aneurysm coil embolization. METHODS: In a retrospective analysis of
390 aneurysmal coiling procedures, we identified 39 patients (10.0%) with thromboembolic …
periprocedural morbidity associated with the endovascular treatment of intracranial
aneurysms with detachable coils. OBJECTIVE: To estimate the safety and efficacy of using
combined intra-arterial and intravenous abciximab to treat thrombi complicating
endovascular cerebral aneurysm coil embolization. METHODS: In a retrospective analysis of
390 aneurysmal coiling procedures, we identified 39 patients (10.0%) with thromboembolic …